Tocilizumab Versus Anakinra in COVID-19: Results from Propensity Score Matching
FRONTIERS IN IMMUNOLOGY(2023)
Key words
anakinra,tocilizumab,anti-interleukin drugs,COVID-19,mortality,SARS-CoV-2,anti-interleukin 6,interleukin 1 receptor antagonist
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined